Company Monitoring Page for Ultragenyx

job ratings for Ultragenyx

09/09/20
industry:
Bio Tech/Pharma
job title:
Medical
company:
Ultragenyx
job rating:
7
Promising pipeline, great culture, mutual respect, transparent communication, collaboration amongst colleagues great and timely. Patient focused!
09/20/17
industry:
Bio-pharmaceutical
company:
Ultragenyx
job rating:
3
Mass confusion - no leadership, little regard for coming together and getting it done.

latest headlines for company on cafepharma

Ultragenyx says Angelman therapy is working, but safety questions remain
BioPharma Dive
Tue, 04/16/24 - 07:49 am
Tags:
Ultragenyx, Angelman Syndrome, GTX-102
Family of Henrietta Lacks sues Ultragenyx over use of HeLa cell line
BioPharma Dive
Sun, 08/13/23 - 02:25 pm
Tags:
Henrietta Lacks, Ultragenyx, legal
Roche drops antisense drug after seeing efficacy data, leaving Biogen, Ionis and Ultragenyx to duke it out
Fierce Biotech
Fri, 06/23/23 - 09:46 am
Tags:
Roche, Angelman Syndrome, antisense, Biogen, Ionis Pharmaceuticals, Ultragenyx, rugonersen
mRNA non-vaccine therapeutics field set to reach $2 billion by 2028
Clinical Trials Arena
Tue, 11/8/22 - 10:54 am
Tags:
MRNA, drug development, Moderna Therapeutics, Ultragenyx, Omega Therapeutics, BioNTech, cancer, OTX-2002
Unpacking Royalty Pharma
EP Vantage
Mon, 07/18/22 - 10:24 am
Tags:
Royalty Pharma, Ultragenyx
Ultragenyx strikes deal with struggling Abeona for rare disease gene therapy
BioPharma Dive
Tue, 05/17/22 - 10:30 pm
Tags:
Ultragenyx, Sanfillipo Syndrome, gene therapy, Abeona Therapeutics
Regeneron hands off ex-US rights for cholesterol disorder drug to rare disease specialist Ultragenyx
Endpoints
Fri, 01/7/22 - 10:36 am
Tags:
Regeneron, evinacumab, Ultragenyx
Ultragenyx granted go-ahead to up doses for Angelman antisense therapy that stalled after safety issues
Fierce Biotech
Wed, 01/5/22 - 10:32 pm
Tags:
Ultragenyx, GeneTx Biotherapeutics, Angelman Syndrome, clinical trials, antisense, GTX-102
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Thu, 05/13/21 - 12:04 pm
Tags:
Rare Diseases, Rare Disease Company Coalition, drug development, drug discovery, Acceleron, Aeglea BioTherapeutics, Agios Pharmaceuticals, Alnylam, Harmony Biosciences, Orchard Therapeutics, Orphazyme, Sarepta Therapeutics, Taysha Gene Therapies, Ultragenyx
Ultragenyx earns 2 rare disease drug approvals—and a validated commercial strategy
Fierce Pharma
Fri, 01/29/21 - 10:00 am
Tags:
Ultragenyx, FDA, Crysvita, tumor-induced osteomalacia, Kyowa Kirin, Dojolvi
Biotech Mereo BioPharma pens $50M Ultragenyx deal for rare bone disease drug
Fierce Biotech
Fri, 12/18/20 - 11:41 am
Tags:
Mereo BioPharma, Ultragenyx, setrusumab, osteogenesis imperfecta
Ultragenyx pauses antisense trial after patients lose ability to walk
Fierce Biotech
Tue, 10/27/20 - 10:40 am
Tags:
Ultragenyx, clinical trials, GTX-102, antisense
Ultragenyx Pharma Wins FDA’s First Drug Nod for Rare Metabolic Disorder
Xconomy
Tue, 06/30/20 - 11:35 pm
Tags:
Ultragenyx, FDA, long-chain fatty acid oxidation disorders, Dojolvi
Ultragenyx's Crysvita scores FDA nod in 2nd ultra-rare bone disorder
Fierce Pharma
Thu, 06/18/20 - 08:31 pm
Tags:
Ultragenyx, Kyowa Kirin, Crysvita, FDA, tumor-induced osteomalacia
What Sanofi Might Buy With Its Regeneron Windfall
Barron's
Wed, 05/27/20 - 11:01 am
Tags:
Sanofi, Regeneron, M&A, gene therapy, Ultragenyx, Bluebird Bio
Ultragenyx shares jump on 'better than expected' gene therapy data
Fierce Biotech
Fri, 01/10/20 - 10:26 am
Tags:
Ultragenyx, clinical trials, gene therapy, DTX301
Ultragenyx gene therapy data disappoints investors
Biopharma Dive
Thu, 09/5/19 - 08:15 pm
Tags:
Ultragenyx, gene therapy, DTX401, glycogen storage disorder, clinical trials
Ultragenyx Inks a Partner-to-Buy Deal with GeneTx to Develop Treatment for Rare Genetic Syndrome
BioSpace
Thu, 08/15/19 - 12:20 pm
Tags:
Ultragenyx, GeneTx Biotherapeutics, Angelman Syndrome, M&A
Crysvita sales push Ultragenyx ahead for the quarter
BioCentury
Fri, 08/2/19 - 12:24 am
Tags:
Ultragenyx, Crysvita, earnings
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
Tags:
biotech, earnings, Immunic, Alkermes, Conatus, Aevi Genomic, Tricida, Curis, Ultragenyx, Leap Therapeutics, Cidara Therapeutics, Akcea, Spark Therapeutics, Eli Lilly, AnaptysBio, clinical trials

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.